Latest News

Buzzi (BIT:BZU) FY 2025 earnings snapshot Buzzi (BIT:BZU) has reported its FY 2025 first half results with revenue of €2.2b and basic EPS of €2.13, setting the tone for how the year is shaping up for shareholders. The company has seen revenue move from €2.1b in the first half of 2024 to €2.2b in the latest half, while basic EPS went from €2.28 to €2.13, against trailing twelve month EPS of €5.00 and revenue of €4.5b. These figures help frame the current performance in a broader context. With...

In recent months, Bernstein Private Wealth Management, a unit of AllianceBernstein L.P., expanded Kim Mustin’s role to a national leadership position overseeing the firm’s Business Owner segment, which focuses on advising private business owners on selling and monetizing their companies. The firm also reported that new business in this segment is accelerating, with its first-quarter 2026 run rate already nearly one-third of the full-year 2025 total, highlighting how focused leadership can...

In March 2026, Patrick Industries, Inc. unveiled The Experience, a collaborative digital design studio in its Elkhart, Indiana Design Center, anchored by a 50-by-14-foot ultra-high-resolution LED screen and a new Digital Twin process to help OEMs rapidly visualize and refine full-scale RV, marine, powersports, and housing products. This initiative highlights Patrick’s push to integrate advanced visualization and virtual prototyping into its offering, potentially tightening customer...

Contiocean Environment Tech Group (SEHK:2613) has released its FY 2025 numbers with first half revenue of C¥143.5 million and basic EPS of C¥0.18, set against trailing twelve month revenue of C¥421.4 million and EPS of C¥1.27. The company has seen revenue move from C¥336.5 million in the first half of FY 2024 and C¥277.9 million in the second half, while EPS shifted from C¥2.75 to C¥1.24 across those periods. This gives investors a clear view of how the latest figures sit against recent...

GE HealthCare Technologies (GEHC) has put its Photonova Spectra photon-counting CT system in the spotlight after securing U.S. FDA 510(k) clearance, a regulatory milestone that validates commercial use for advanced cardiac imaging. See our latest analysis for GE HealthCare Technologies. The FDA 510(k) clearance for Photonova Spectra arrives after a period in which GE HealthCare’s 1 month share price return of 10.2% and year to date share price return of 13.09% have been weak. At the same...

Teledyne Technologies (NYSE:TDY) has secured a major contract with the UK Ministry of Defence to supply autonomous ocean observing systems for the Royal Navy. The company has reorganized its space focused operations into a new initiative called Teledyne Space, combining multiple space related capabilities. These moves highlight Teledyne's focus on advanced maritime and space technologies that are closely tied to defense and national security needs. For investors tracking NYSE:TDY, the new...

Earnings surprise and guidance put focus on Lattice Semiconductor Lattice Semiconductor (LSCC) drew attention after reporting quarterly revenue above expectations, tighter inventories, and data center strength linked to AI, while issuing next quarter revenue guidance that also topped analyst forecasts. See our latest analysis for Lattice Semiconductor. The latest results come after a sharp run in the share price, with a 90 day share price return of 29.85% and a 1 year total shareholder return...

Recent shareholder litigation and board-level fiduciary duty questions have pushed Fiserv (FISV) into focus, as a class action complaint and law firm investigation intersect with cautious analyst ratings and a consensus Hold stance. See our latest analysis for Fiserv. At a share price of US$55.45, Fiserv has a 1 month share price return of 10.35% and a year to date share price return of 15.46%. The 1 year total shareholder return of 75.48% and 5 year total shareholder return of 54.96% point...

In March 2026, the FDA’s Center for Biologics Evaluation and Research issued an untitled letter to Iovance Biotherapeutics over Amtagvi promotional materials, citing potentially misleading references to overall survival data and giving the company 15 working days to respond. This regulatory pushback highlights the sensitivity around how Iovance communicates clinical outcomes for its first commercial product, a key element of its growth ambitions. We’ll now explore how the FDA’s concerns over...

Context for CareTrust REIT after recent price moves CareTrust REIT (CTRE) has seen mixed share performance recently, with a gain of 1.3% over the past day, a small decline over the past week, and a larger drop over the past month. See our latest analysis for CareTrust REIT. That short term weakness sits alongside a 2.3% year to date share price return and a 35.5% total shareholder return over the past year, supported by even stronger 3 and 5 year total shareholder returns. If CareTrust REIT’s...

Recent performance snapshot TDK (TSE:6762) has drawn attention after a recent stretch of weaker share performance, with the stock showing negative returns over the past week, month, past 3 months, and year to date. See our latest analysis for TDK. The recent 6.15% 1 day and 13.53% year to date share price declines contrast with TDK's stronger 1 year and 3 year total shareholder returns of 38.84% and 128.38%. This suggests that momentum has cooled following a strong multi year period. If you...

If you are wondering whether Takeda Pharmaceutical's current share price lines up with its underlying worth, this breakdown is aimed squarely at you. The stock last closed at ¥5,890, with returns of 1.7% over 7 days, 2.8% over 30 days, 19.8% year to date, 35.0% over 1 year, 52.0% over 3 years, and 98.2% over 5 years, which gives plenty of recent performance data to weigh against valuation. Recent news coverage has focused on Takeda Pharmaceutical's position in the pharmaceutical sector and...

Amundi has filed its 2025 Universal Registration Document with the French regulator AMF, making updated financial, sustainability, governance and auditor-fee disclosures available to investors in both French and English. At the same time, the internal promotion of Cornil to Chief Operating Officer highlights Amundi’s focus on reinforcing its operational backbone within its asset management franchise. Next, we’ll examine how the COO appointment may influence Amundi’s existing investment...

If you are wondering whether Tripadvisor is a bargain at its current share price or cheap for a reason, this article breaks down what the market might be implying about its value. The stock last closed at US$10.71, with a 12.6% return over the past week and 7.3% over the past month, but a 26.8% decline year to date and a 25.2% decline over the past year. Recent headlines around Tripadvisor have focused on ongoing competition among travel platforms and how consumer behavior is evolving as...

Why Rai Way's latest dividend and earnings update matters for shareholders Rai Way (BIT:RWAY) has put fresh numbers in front of investors, pairing its full year 2025 results with news of a reduced annual dividend of €0.33 per share, payable in May 2026. The combination of lower cash returns and pressure on net income has sharpened the focus on what investors are getting for every euro invested in the stock, especially with Rai Way operating as a pure play Italian tower and broadcasting...

Garmin (NYSE:GRMN) has entered a partnership with Natural Cycles to integrate FDA cleared fertility and reproductive health tracking into compatible Garmin smartwatches. The collaboration brings non hormonal birth control and detailed fertility insights to Garmin's wearable platform through Natural Cycles' approved algorithm. The integration extends Garmin's health tracking capabilities into reproductive health, targeting users seeking data driven support for cycle tracking and family...

In recent months, Deckers Outdoor has earned a Zacks Rank #1 (Strong Buy) after a series of quarterly earnings and revenue beats and upward analyst estimate revisions, reflecting improved expectations for its near‑term performance. At the same time, the company’s constant-currency growth and operating margin have trailed industry benchmarks, highlighting an interesting contrast between analyst optimism and underlying profitability pressures. We’ll now examine how this stronger analyst...

On March 17, 2026, at the NVIDIA AI Conference & Expo, Nvidia announced a collaboration with Coupang to build an AI factory that combines Coupang Intelligent Cloud with Nvidia DGX SuperPOD, creating a self-service environment for developing and testing AI models across its global e-commerce, logistics, and delivery operations. This effort positions Coupang as a launch partner for Nvidia Dynamo and signals a deeper integration of advanced AI into its Rocket Delivery and fulfillment network,...

Investors may be wondering if Groupe Dynamite at around $75.61 still offers value after its huge run, or if most of the opportunity is already reflected in the price. The stock has delivered a 445.2% return over the last year, while the most recent returns show a 0.4% decline over 7 days, an 11.3% decline over 30 days, and a 6.7% decline year to date. Recent coverage has focused on how such a sharp one year move can reset expectations around risk and reward. Investors are paying closer...

Okaya (NSE:7485) has just wrapped up FY 2026 with fourth quarter revenue of ¥292.4b and basic EPS of ¥349.92, while the trailing twelve months show revenue of ¥1.2t and EPS of ¥1,585.43 alongside net income of ¥30.5b. Over recent periods, revenue has moved around the ¥292.7b to ¥293.9b range per quarter, with basic EPS between ¥349.92 and ¥463.06, giving a clear view of how the top line and per share earnings have tracked together. With the current earnings profile, margin trends and existing...

In recent weeks, Celsius Holdings reported quarterly revenue of US$721.63 million and earnings per share of US$0.26, both beating analyst estimates, while Deutsche Bank upgraded its rating after reassessing competition from Costco’s private-label energy drink and the company’s integration of Alani Nu and Rockstar. Together with Celsius’s roughly 20% share of U.S. energy drink dollars and expectations for gross margin recovery to the low 50s by mid-2026, these developments highlight how brand...

As Canada navigates a complex economic landscape marked by fluctuating oil prices and inflationary pressures, investors are increasingly looking at diverse opportunities to balance potential risks and rewards. Penny stocks, despite their somewhat outdated name, continue to attract attention for their ability to offer surprising value when backed by strong financials. In the following discussion, we explore several promising penny stocks that stand out for their financial strength and...

Why Kodiak Gas Services is on investors’ radar Kodiak Gas Services (KGS) has drawn attention after a strong past 3 months, with the stock showing a 54.8% total return while operating a US focused contract compression and services business. See our latest analysis for Kodiak Gas Services. That recent 54.8% 3 month share price return contrasts with a softer 7 day share price return of a 2.1% decline. The latest close at $57.90 sits against a 1 year total shareholder return of 57.3%, suggesting...

Eli Lilly (NYSE:LLY) received U.S. FDA approval for Foundayo, its first oral, once-daily GLP-1 weight loss pill for obesity and overweight patients with related conditions. The company launched Foundayo commercially in the U.S. immediately after approval, making it available through LillyDirect and retail pharmacies. Foundayo can be taken at any time without food or water restrictions and is being introduced with tailored pricing to broaden access. Eli Lilly enters a new phase in obesity...